Profile
Ms. Ola Melin is a Chief Operating Officer at Circio Holding ASA. Ms. Melin was previously employed as a Director-Technical Operations by OxThera AB and a Director-Extended Manufacturing by Swedish Orphan Biovitrum AB. She received her undergraduate degree from Mälardalen University.
Ola Melin active positions
| Companies | Position | Start |
|---|---|---|
| CIRCIO HOLDING ASA | Chief Operating Officer | - |
Former positions of Ola Melin
| Companies | Position | End |
|---|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Chief Tech/Sci/R&D Officer | - |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Education of Ola Melin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Mälardalen University
Mälardalen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Circio Holding ASA
Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
- Stock Market
- Insiders
- Ola Melin
















